• Set Text Size  

MG In the News

The latest info for the MG community is right here! 


MGFA Poised for 2021 Coast-to-Coast Walk 2740 Challenge

Myasthenia Gravis News

September 16, 2021

With the goal of raising funds and awareness to improve care and find a cure for myasthenia gravis (MG), the Myasthenia Gravis Foundation of America (MGFA) is hosting the 2021 Coast-to-Coast Walk and 2740 Challenge on Nov. 13.


Australian wheelchair rugby player overcomes rare disease to be in the Paralympics

Tokyo Paralympic.org

August 27, 2021

Richard Voris was left out of Australia’s wheelchair rugby team that won the Rio 2016 gold medal, despite being a regular in the squad since 2013. The reason was an autoimmune disease called Myasthenia Gravis. But he is back!


Unstoppable Glenda Thomas Made Incredible Accomplishments Despite her MG

Authority Magazine

July 12, 2021

As part of our “Unstoppable” series, I had the pleasure of interviewing Glenda Thomas. She was diagnosed with MuSK myasthenia gravis (MG) and has been an active volunteer for the Myasthenia Gravis Foundation of America


Together We are Turning Awareness into Action

Metropolis Planet

June 16, 2021

In fact, at that time, I had never even heard of Myasthenia Gravis (MG). Now, during the month of June, we are #MGSTRONG, and together, we “Turn MG Awareness into Action.”


Framingham's Glenda Thomas Named to Serve on State Rare Disease Board

MetroWest Daily News

June 7, 2021

The Framingham resident recently added another title to her ever-growing resume. Thomas was recently appointed to the newly formed Rare Disease Advisory Council of Massachusetts.


MGFA Events Set to ‘Turn Awareness Into Action’ Throughout June

Myasthenia Gravis News

June 1, 2021

MG Action Month — Turning Awareness into Action is this year’s theme. MGFA has a host of events and activities planned, including a live, virtual interactive map that showcases individual stories, with states and countries “lighting up” to indicate Awareness Month activity. The organization is inviting the entire MG community to participate.


NEWS RELEASE: Glenda Thomas Selected as Member of the Rare Disease Advisory Council of Massachusetts

May 25, 2021

Glenda Thomas, an MG advocate, patient, and Bay State resident who has been an extremely active volunteer, has been appointed as the first-ever MG advocate to the newly-established Rare Disease Advisory Council of Massachusetts. Glenda will be publicly sworn in during an online ceremony on Thursday, May 27, 2021 at 11:30 a.m Eastern. Read the News Release to access the zoom link for the online ceremony. 


Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis

JAMA Neurology

May 4, 2021

Does the response to rituximab differ between patients with new-onset vs refractory generalized myasthenia gravis, and how does rituximab compare with conventional immunotherapy in these patients?


NEWS RELEASE: Myasthenia Gravis Foundation of America Presents Annual Volunteer Awards at 2021 National Conference

April 11, 2021

Largest Patient Advocacy Organization Solely Committed to Myasthenia Selects MG Community Members for Prestigious Awards that Recognize Impact, Advocacy, and Dedication


Her Eyelid Drooped and She Kept Getting Weaker. What Was Going On?

New York Times Magazine

March 4, 2021

Dozens of tests turned up nothing. Then a specialist had a theory. It was myasthenia gravis.


MG Patients Should Be Priority for COVID-19 Vaccine, Report Says, Citing Risks

Myasthenia Gravis News

March 2, 2021

University of Arkansas data suggests MG patients should be positioned higher in the eligibility list to receive the COVID-19 vaccines.


Secrets to Living Longer and Feeling Healthy with Plant-based Diet

The Beet

February 13. 2021

MG patient Fran German and husband switch to plant-based diet and feel younger and healthier.


National Organization for Rare Disorders (NORD) Adds MG to RareCare Support Network

NORD Website

January 24, 2021

NORD has added myasthenia to its RareCare support network. The network provides assistance programs to help patients obtain life-saving or life-sustaining medication they could not otherwise afford. https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/ You can find out more about the MG Patient Assistance Programs and other supportive patient assistance from NORD HEREbit.ly/NORDAssistance


argenx Officially Files for FDA approval of Efgartigimod for Generalized MG

Myasthenia Gravis News

January 12, 2021

argenx has officially files for U.S. FDA approval of Efgartigimod for generalized MG.


Double-seropositive myasthenia gravis: a distinct subtype?

Neurological Sciences

January 12, 2021

This study investigated the characteristics of double-seropositive myasthenia gravis (DSP-MG) in southern China for disease subtype classification.


2020 Coverage


AstraZeneca Agrees to Acquire Alexion, the Maker of Soliris, for $39 Billion 


December 12, 2020

Alexion, a Boston-based rare disease pharmaceutical and MGFA industry partner, has entered into an agreement to be acquired by AstraZeneca, one of the world’s largest drug companies.  READ MORE

My Cause, My Cleats: Dexter Williams of the Green Bay Packers Supports MG Awarenesss

Packers.com/Sports Illustrated

December 6, 2020

Dexter Williams of the NFL Green Bay Packers decorates his cleats to direct attention to those with myasthenia during annual "My Cause, My Cleats" initiative. READ MORE


International Experts Update, Expand MG Management Guidelines

Myasthenia Gravis News

December 4, 2020

A panel of 16 international experts, initially selected by MGFA, has updated and expanded recommendations for best management of myasthenia gravis (MG). READ MORE


MDA Wants Neuromuscular Disease Patients to have Early Access to COVID-19 Vaccine

Myasthenia Gravis News

December 4, 2020

The Muscular Dystrophy Association is encouraging the U.S. CDC to recommend that people living with neuromuscular diseases (NMDs) such as myasthenia have early access to any federally approved COVID-19 vaccine. READ MORE


Plasma Shortage Intensified Because of COVID-19

The Morgan Hill Times

October 7, 2020

With the Covid-19 pandemic cancelling many donation drives throughout the nation, the Myasthenia Gravis Foundation of America is reporting a severe shortage of plasma donations. Read interview with volunteer Deborah Vick. READ MORE


Research survey for rare disease patients and their families about impacts of COVID-19

MGFA Published Survey

April, 2020

How is the novel coronavirus pandemic impacting people with rare diseases and their families? Complete the 20-minute research survey from home or learn more at this link. The Rare Diseases Clinical Research Network (RDCRN) is conducting this study. The network is funded by the National Institutes of Health. It includes 23 research teams working to advance diagnosis and treatment of groups of rare diseases. The Myasthenia Gravis Foundation of America and Conquer MG partners with RDCRN through its work with the Myasthenia Gravis Rare Disease Network (MGNet).


Guidance for the management of Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS) during the COVID-19 pandemic

International MG/COVID Working Group

March 23, 2020 
International MG/COVID-19 Working Group1SaijuJacoba2SrikanthMuppidib2AmandaGuidoncJeffreyGuptilldMichaelHehireJames F.HowardJrfIsabelIllagRenatoMantegazzahHiroyukiMuraiiKimiakiUtsugisawajJohnVissingkHeinzWiendllRichard J.Nowakm2

Coronavirus Disease 2019 (COVID-19) is a new illness caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms are variable but typically include fever, cough, respiratory symptoms, diarrhea, reduction of smell and taste sensation. Severity ranges from mild to severe and the virus may lead to pneumonia, acute respiratory distress syndrome and death, in some patients. Nearly every country in the world has been affected by this virus and is currently defined as a pandemic, by the World Health Organization. There are no known proven therapies for treating this virus and no vaccine to prevent the infection at this time. 

The full guidance is available here

MGNet Webinar- "Myasthenia Gravis and the COVID-19 Epidemic: Things for you to know" 

MGFA Program

March 18, 2020

Presenters: Hana Axelrod, MD, MPH; Henry J. Kaminski, MD; Helen Girma, George Washington University Department of Neurology
We are pleased to share that the MGNet webinar, “MG and COVID-19: Things for you to Know” has been recorded and is available for viewing. We apologize for any technical difficulties in registering or participating in the webinar on March 18.

To view the recording of this webinar, please see here


MG Walks and COVID-19 (Coronavirus)

MGFA Fundraising News

March 2020

The health and safety of our participants, sponsors, volunteers and staff is our top concern. Currently, ALL spring walks from March 14-May 30 have been postponed until further notice. Additional details can also be found on our MG Walk website here.
We will look at potential dates for this fall and keep you updated as we learn more.  If we are able to secure a fall date, then all donations will roll over to the new walk date. 

**Any decisions made going forward will absolutely be dependent on where we are at with this global health crisis.

COVID-19 (Coronavirus)- General Information and Management 

MGFA New Resources

March 2020

Due to the recent news regarding COVID-19 (coronavirus), we are providing some guidance around COVID-19, as well as reliable sources for information. See more information here


MGFA announces 2020 research funding opportunities

We are pleased to announce the release of our Request for Applications for our High Impact Clinical Research and Scientific Pilot Projects on Myasthenia Gravis and Related Neuromuscular Junction Disorders.

We are also very pleased to announce our first targeted research opportunity to benefit the Seronegative MG community

To learn about our research agenda and complete funding opportunities, see here


University of California, San Francisco, Launches First Consortium on Pediatric MG in Partnership with MGFA and MDA

For families with children that have myasthenia gravis, we have some exciting news to share. Thanks to a generous gift from an anonymous donor to the University of California, San Francisco, the first clinical Pediatric Myasthenia Gravis Consortium is now a reality.  MGFA was honored to provide a grant to underwrite the costs for the September inaugural meeting of this exciting new project, and to participate on the advisory committee for the Consortium.


GW Researchers Receive $7.8 Million to Establish Rare Disease Network for Myasthenia Gravis, MGNet, supported by commitments from MGFA and Conquer MG

MGFA is proud to represent the MG Community as a member of MG Net, and has committed $250,000 of funding ($50,000 for each year) to support the project.  This commitment from MGFA, as well as that of Illinois-based Conquer MG, was instrumental in demonstrating the support of the MG Community for the project—an essential component of the criteria for funding established by the NIH. Press release available here


The National Institutes of Health (NIH) has awarded a research team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. The network, which will be part of 25 established NIH Rare Diseases Clinical Research Networks, will include basic and clinical investigators, patient advocacy groups and biotechnology and pharmaceutical companies working together to enhance therapeutic development for this rare disease.  The team is led by former and current MGFA Medical and Scientific Advisory (MSAB) Chairs, Henry Kaminski, MD and Linda Kusner, PhD, and the steering committee members are all leaders of the MGFA MSAB as well. 


The grant will fund research into the underlying pathophysiology of the disease, provide fellowships in MG for young investigators, and fund pilot grants.  This funding will also ensure that the serum bank created by the MGFA’s transformative grant will continue.  


MGFA’s 2020 Virtual Conference, April 5-7- Recorded Presentations Available Here

To view recorded presentations, resources and sponsor information, please complete a brief registration form and visit our virtual conference space here.  Please see some helpful tips for navigating our virtual conference space here


Information on treatments, research and news that affects the MG community can change in an instant. We are your source for the latest, trusted information on MG.  Add your email address to our mailing list to receive information on research, clinical trial opportunities, MG events and more direct to your inbox!


Magazines & Newsletters 

A World Without MG